| |
Units
|
Pattern I MS
|
Pattern II + III MS
|
Pattern II MS
|
Pattern III MS
|
AQP4-IgG+ NMO [48]
|
|---|
|
CSF TP elevated
|
Patients
|
3/9 (33.3)
|
14/20 (70)
|
8/13 (61.5)
|
6/7 (85.7)
|
n.d.
|
|
CSF TP elevated
|
Samples
|
3/15 (20)
|
29/43 (67.4)
|
15/26 (57.7)
|
14/17 (82.4)
|
80/152 (52.6)
|
|
CSF TP, all LPs
|
mg/L
|
375 (187–750; 15)
|
550 (168–1930; 43)
|
501 (168–1930; 26)
|
640 (260–1277; 17)
|
473 (198–3620; 147)
|
|
CSF TP, if elevated
|
mg/L
|
724 (532–750; 3)
|
622 (470–1930; 29)
|
571 (471–1930; 15)
|
693 (470–1277; 14)
|
780 (45.4–3620; 68)
|
|
CSF TP, >750 mg/L
|
mg/L
|
0/15 (0)
|
8/43 (18.6)
|
4/26 (15.4)
|
4/17 (23.5)
|
41/147 (28)
|
|
CSF lactate elevated
|
Patients
|
2/8 (25)
|
6/14 (42.9)
|
5/11 (45.5)
|
1/3 (33.3)
|
n.d.
|
|
CSF lactate elevated
|
Samples
|
2/9 (22.2)
|
7/28 (25)
|
6/20 (30)
|
1/8 (12.5)
|
27/83 (32.5)
|
|
CSF lactate, all LPs
|
mmol/L
|
1.3 (1.1–2.35; 11)
|
1.9 (0.8–3.3; 28)
|
1.85 (0.8–3.3; 20)
|
1.9 (1.36–2.9; 8)
|
1.97 (0.87–6.8; 80)
|
|
CSF lactate, if elevated
|
mmol/L
|
2.175 (2–2.35; 2)
|
2.5 (2.2–3.3; 7)
|
2.4 (2.2–3.3; 6)
|
2.9 (2.9–2.9; 1)
|
2.9 (2.1–6.8; 27)
|
|
CSF lactate, >3 mmol/L
|
mmol/L
|
0/11 (0)
|
1/28 (3.6)
|
1/20 (5)
|
0/8 (0)
|
27/80 (33.8)
|
-
n.d. no data
- Concentrations are reported as medians; range and total sample numbers examined are given in brackets
